On April 27, Axinn partner Chad Landmon spoke at the FDLI webinar, "Biologic and Biosimilar Litigation and IP Rights." Speakers discussed recent case law related to patent term exclusivity, United States Patent and Trademark Office (USPTO) proceedings, and important recent and pending Courts of Appeal decisions.

Click here for more information.